Stemline Therap Company Profile
✉ Email this page to a colleague
What is the competitive landscape for STEMLINE THERAP, and when can generic versions of STEMLINE THERAP drugs launch?
STEMLINE THERAP has one approved drug.
There are eight US patents protecting STEMLINE THERAP drugs.
There are one hundred patent family members on STEMLINE THERAP drugs in twenty-five countries and five supplementary protection certificates in five countries.
Summary for Stemline Therap
International Patents: | 100 |
US Patents: | 8 |
Tradenames: | 1 |
Ingredients: | 1 |
NDAs: | 1 |
Drugs and US Patents for Stemline Therap
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Stemline Therap | ORSERDU | elacestrant dihydrochloride | TABLET;ORAL | 217639-001 | Jan 27, 2023 | RX | Yes | No | 7,612,114 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Stemline Therap | ORSERDU | elacestrant dihydrochloride | TABLET;ORAL | 217639-002 | Jan 27, 2023 | RX | Yes | Yes | 10,745,343 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Stemline Therap | ORSERDU | elacestrant dihydrochloride | TABLET;ORAL | 217639-002 | Jan 27, 2023 | RX | Yes | Yes | 7,612,114 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Stemline Therap Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Australia | 2016256469 | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 2018129419 | ⤷ Try a Trial |
Mexico | 2019007748 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Stemline Therap Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
3122426 | 301263 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: ELACESTRANT OF EEN ZOUT DAARVAN; REGISTRATION NO/DATE: EU/1/23/1757 20230918 |
3122426 | 2024C/505 | Belgium | ⤷ Try a Trial | PRODUCT NAME: ELACESTRANT OU UN SEL DE CELUI-CI; AUTHORISATION NUMBER AND DATE: EU/1/23/1757 20230918 |
3122426 | LUC00331 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: ELACESTRANT OU UN SEL DE CELUI-CI; AUTHORISATION NUMBER AND DATE: EU/1/23/1757 20230918 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.